Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Legacy Good Samaritan Hospital demonstrates breast-specific gamma imaging benefits

Dilon Technologies : 30 April, 2008  (Application Story)
A group of surgeons from Legacy Good Samaritan Hospital in Portland, Oregon, USA, have demonstrated the value of using Breast-Specific Gamma Imaging (BSGI) for the clinical management of breast cancer patients.
The data has been published in The American Journal of Surgery.

The breast centre's first year's experience with BSGI showed the upside of using physiological data obtained from the functional imaging of BSGI over imaging techniques that convey mostly anatomical data - such as mammography, Ultrasound and MRI. Specifically, the results of the study showed that BSGI:

- Changed patient management in 14 percent of the cases;

- Detected cancer in two percent of patients with no mammographic findings;

- Detected additional cancers in six percent of patients with known breast disease;

- Correctly ruled out the need for biopsy in 86 percent of patients with suspicious mammograms;

- Had a false positive rate of only six percent, as compared to 78 percent in acomparable MRI study.

The surgeons noted that breast density can cause the effectiveness of mammography to greatly decrease, so other imaging tests are needed to help address this group of high-risk patients. BSGI is not affected by breast density and has exhibited not only high sensitivity for detecting cancer, but also a strong ability to help rule it out.

In the retrospective study, performed by Dr Nathalie Johnson and colleagues, BSGI was determined to play an important role in their management of patients with complex breast tissue and newly diagnosed cancers. In addition, Legacy Good Samaritan Hospital noted that cost of BSGI was one-third that of MRI for their facility.

Dr David Maccabee, a surgeon practicing in Hood River, Oregon, stated, the data was clinically relevant and may change the way surgeons practice surgery in the future.

Dilon Technologies’ Dilo 6800, is a high-resolution, small field-of-view gamma camera, optimised to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo